Advertisement

Acute Vision Loss

  • Brit Long
  • Alex Koyfman
Chapter

Abstract

Acute vision loss has many etiologies with a large differential. These conditions can range from benign to those resulting in permanent vision loss. Many of these diagnoses are time-sensitive, and the emergency physician may improve patient outcome through the consideration of several acute etiologies. This chapter evaluates the emergency medicine evaluation and management of vision loss.

Keywords

Ophthalmology Acute Chronic Vision loss Vision deficit 

References

  1. 1.
    Burde R, Savino P, Trobe J. Clinical decisions in neuro-ophthalmology. 3rd ed. St. Louis: Mosby; 2002.Google Scholar
  2. 2.
    Walker RA, Adhikaris S. Chap. 241. Eye emergencies. In: Tintinalli’s emergency medicine: a comprehensive study guide. 8th ed. New York: McGraw-Hill; 2016.Google Scholar
  3. 3.
    Guluma K, Lee JE. Ophthalmology. In: Rosen’s emergency medicine, Chapter 61. p. 780–8190.e3.Google Scholar
  4. 4.
    Colby K. Management of open globe injuries. Int Ophthalmol Clin. 1999;39:59.CrossRefPubMedGoogle Scholar
  5. 5.
    Unver YB, Kapran Z, Acar N, Altan T. Ocular trauma score in open-globe injuries. J Trauma. 2009;66:1030.CrossRefPubMedGoogle Scholar
  6. 6.
    Thakker MM, Ray S. Vision-limiting complications in open-globe injuries. Can J Ophthalmol. 2006;41:86.CrossRefPubMedGoogle Scholar
  7. 7.
    Friedlaender MH. A review of the causes and treatment of bacterial and allergic conjunctivitis. Clin Ther. 1995;17:800.CrossRefPubMedGoogle Scholar
  8. 8.
    Weiss A, Brinser JH, Nazar-Stewart V. Acute conjunctivitis in childhood. J Pediatr. 1993;122:10.CrossRefPubMedGoogle Scholar
  9. 9.
    Walton W, Von Hagen S, Grigorian R, Zarbin M. Management of traumatic hyphema. Surv Ophthalmol. 2002;47:297.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Brandt MT, Haug RH. Traumatic hyphema: a comprehensive review. J Oral Maxillofac Surg. 2001;59:1462.CrossRefPubMedGoogle Scholar
  11. 11.
    Pashby T. Eye injuries in Canadian amateur hockey. Can J Ophthalmol. 1985;20:2.PubMedGoogle Scholar
  12. 12.
    Sankar PS, Chen TC, Grosskreutz CL, Pasquale LR. Traumatic hyphema. Int Ophthalmol Clin. 2002;42:57.CrossRefPubMedGoogle Scholar
  13. 13.
    Guly CM, Forrester JV. Investigation and management of uveitis. BMJ. 2010;341:c4976.CrossRefPubMedGoogle Scholar
  14. 14.
    Jabs DA, Busingye J. Approach to the diagnosis of the uveitides. Am J Ophthalmol. 2013;156:228.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Rosenbaum JT. Nibbling away at the diagnosis of idiopathic uveitis. JAMA Ophthalmol. 2015;133:146.CrossRefPubMedGoogle Scholar
  16. 16.
    Pokhrel PK, Loftus SA. Ocular emergencies. Am Fam Physician. 2007;76:829.PubMedGoogle Scholar
  17. 17.
    See JLS, PTK C. Angle-closure glaucoma. In: Yanoff M, Duker JS, editors. Ophthalmology. 3rd ed. St. Louis: Mosby; 2009. p. 1162.CrossRefGoogle Scholar
  18. 18.
    D’Amico DJ. Clinical practice. Primary retinal detachment. N Engl J Med. 2008;359:2346.CrossRefPubMedGoogle Scholar
  19. 19.
    Hikichi T, Trempe CL, Schepens CL. Posterior vitreous detachment as a risk factor for retinal detachment. Ophthalmology. 1995;102:527.CrossRefPubMedGoogle Scholar
  20. 20.
    Mandelbaum S, Forster RK. Exogenous endophthalmitis. In: Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular immunology and infection. St. Louis: Mosby; 1996. p. 1298.Google Scholar
  21. 21.
    Eagle RC Jr. Mechanisms of maculopathy. Ophthalmology. 1984;91:613.CrossRefPubMedGoogle Scholar
  22. 22.
    Appen RE, Wray SH, Cogan DG. Central retinal artery occlusion. Am J Ophthalmol. 1975;79:374.CrossRefPubMedGoogle Scholar
  23. 23.
    Hayreh SS, Podhajsky PA, Zimmerman MB. Natural history of visual outcome in central retinal vein occlusion. Ophthalmology. 2011;118:119.CrossRefPubMedGoogle Scholar
  24. 24.
    Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol. 1996;114:545.CrossRefGoogle Scholar
  25. 25.
    Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA. 2002;287:92.CrossRefPubMedGoogle Scholar
  26. 26.
    Younge BR, Cook BE Jr, Bartley GB, et al. Initiation of glucocorticoid therapy: before or after temporal artery biopsy? Mayo Clin Proc. 2004;79:483.CrossRefPubMedGoogle Scholar
  27. 27.
    Hunder GG. Giant cell arteritis and polymyalgia rheumatica. In: Kelly WN, Harris ED, Ruddy S, Sledge CB, editors. Textbook of Rheumatology. 5th ed. Philadelphia: WB Saunders; 1996.Google Scholar
  28. 28.
    Balcer LJ. Clinical practice. Optic neuritis. N Engl J Med. 2006;354:1273.CrossRefPubMedGoogle Scholar
  29. 29.
    Foroozan R, Buono LM, Savino PJ, Sergott RC. Acute demyelinating optic neuritis. Curr Opin Ophthalmol. 2002;13:375.CrossRefPubMedGoogle Scholar
  30. 30.
    Frohman EM, Frohman TC, Zee DS, et al. The neuro-ophthalmology of multiple sclerosis. Lancet Neurol. 2005;4:111.CrossRefPubMedGoogle Scholar
  31. 31.
    Arnold AC. Evolving management of optic neuritis and multiple sclerosis. Am J Ophthalmol. 2005;139:1101.CrossRefPubMedGoogle Scholar
  32. 32.
    Seltz LB, Smith J, Durairaj VD, et al. Microbiology and antibiotic management of orbital cellulitis. Pediatrics. 2011;127:e566.CrossRefPubMedGoogle Scholar
  33. 33.
    Nageswaran S, Woods CR, Benjamin DK Jr, et al. Orbital cellulitis in children. Pediatr Infect Dis J. 2006;25:695.CrossRefPubMedGoogle Scholar
  34. 34.
    Zhang J, Stringer MD. Ophthalmic and facial veins are not valveless. Clin Exp Ophthalmol. 2010;38:502.CrossRefPubMedGoogle Scholar
  35. 35.
    Mills R. Orbital and periorbital sepsis. J Laryngol Otol. 1987;101:1242.CrossRefPubMedGoogle Scholar
  36. 36.
    Ferro JM, Canhão P, Stam J, et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664.CrossRefPubMedGoogle Scholar
  37. 37.
    Saposnik G, Barinagarrementeria F, Brown RD Jr, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:1158.CrossRefPubMedGoogle Scholar
  38. 38.
    Acheson JF. Idiopathic intracranial hypertension and visual function. Br Med Bull. 2006;79–80:233.CrossRefPubMedGoogle Scholar
  39. 39.
    Wall M, Kupersmith MJ, Kieburtz KD, et al. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol. 2014;71:693.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Rucker JC, Biousse V, Newman NJ. Ischemic optic neuropathies. Curr Opin Neurol. 2004;17:27.CrossRefPubMedGoogle Scholar
  41. 41.
    Alvord EC Jr, Lofton S. Gliomas of the optic nerve or chiasm. Outcome by patients’ age, tumor site, and treatment. J Neurosurg. 1988;68:85.CrossRefPubMedGoogle Scholar
  42. 42.
    Barceloux DG, Bond GR, Krenzelok EP, et al. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002;40:415.CrossRefPubMedGoogle Scholar
  43. 43.
    Sivilotti ML. Methanol intoxication. Ann Emerg Med. 2000;35:313.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Brit Long
    • 1
  • Alex Koyfman
    • 2
  1. 1.San Antonio Military Medical Center, Department of Emergency MedicineSan AntonioUSA
  2. 2.The University of Texas Southwestern Medical Center, Department of Emergency MedicineDallasUSA

Personalised recommendations